Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-24-090990
Filing Date
2024-08-19
Accepted
2024-08-19 20:59:59
Documents
2
Group Members
AARON GLENN LOUIS FLETCHERBIOS 2024 CO-INVEST, LPBIOS ACTUATE CO-INVEST I, LPBIOS ACTUATE CO-INVEST II, LPBIOS ACTUATE CO-INVEST III, LPBIOS ADVISORS GP, LLCBIOS CAPITAL MANAGEMENT, LPBIOS CLINICAL OPPORTUNITY FUND, LPBIOS EQUITY COF, LPBIOS EQUITY PARTNE

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2421972d1_sc13d.htm SC 13D 576428
2 EXHIBIT 1 tm2421972d1_ex1.htm EX-1 183984
  Complete submission text file 0001104659-24-090990.txt   763010
Mailing Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107
Business Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107 847-986-4190
ACTUATE THERAPEUTICS, INC. (Subject) CIK: 0001652935 (see all company filings)

EIN.: 473044785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-94595 | Film No.: 241222407
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1401 FOCH STREET SUITE 140 FORT WORTH TX 76107
Business Address 1401 FOCH STREET SUITE 140 FORT WORTH TX 76107 817-984-5964
BIOS Fund I, LP (Filed by) CIK: 0001697316 (see all company filings)

EIN.: 815006136 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13D